Clinical Trials

163 enrolled

Stomach Neoplasms

NCT06500273 2026-03-18

ALPHA3

250 enrolled

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07481058 2026-03-18

A Study of KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy as First-line Treatment in Patients With Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma

NCT04486378 2026-03-17

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

327 enrolled

Neoplasms, Colorectal Neoplasms

NCT04634552 2026-03-17

MonumenTAL-1

Other hematologic neoplasmPlasma cell

510 enrolled 1 FDA

Multiple Myeloma, Hematologic Neoplasms

NCT05633667 2026-03-17

VELOCITY-Lung

270 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06157892 2026-03-17

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

172 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT06581432 2026-03-17

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

430 enrolled

Other solid neoplasm

Solid Tumours

NCT06992258 2026-03-17

FRUITION

120 enrolled

Colorectal Neoplasms

NCT07155174 2026-03-17

SEZanne

180 enrolled

Small Cell Lung Carcinoma

NCT07332000 2026-03-17

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

45 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT03547973 2026-03-16

TROPHY U-01

827 enrolled 1 FDA

Genitourinary

Metastatic Urothelial Cancer

NCT04728893 2026-03-16

MK-1026-003

LymphoidOther hematologic neoplasm

490 enrolled

Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Hematologic Neoplasms

NCT06667908 2026-03-16

CONVERGE

130 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06987539 2026-03-16

THYME

15 enrolled

Myasthenia Gravis

NCT06995677 2026-03-16

SURF302

90 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07002034 2026-03-16

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

NCT07052253 2026-03-16

A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

Carcinoma, Hepatocellular

NCT07125872 2026-03-16

Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma

20 enrolled

Lymphoma, B-Cell

NCT07221500 2026-03-16

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07252739 2026-03-16

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

130 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Neoplasms

NCT07368998 2026-03-16

optINAVO

80 enrolled

Breast

Breast Neoplasms

NCT07387471 2026-03-16

Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

14 enrolled

Waldenstrom Macroglobulinemia, Neoplasms, Lymphoma, B-Cell, Marginal Zone

NCT05963074 2026-03-13

TAILOR

LymphoidOther hematologic neoplasm

320 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06008288 2026-03-13

A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

88 enrolled

Pancreatic Neoplasms

NCT06120140 2026-03-13

COCOON

300 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06607458 2026-03-13

DEL-LIVER

90 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT06841055 2026-03-13

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

Carcinoma, Non-Small-Cell Lung

NCT06875128 2026-03-13

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

90 enrolled

Breast

Breast Neoplasms

NCT07023289 2026-03-13

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

140 enrolled

Neoplasms, Colorectal Neoplasms

NCT07149857 2026-03-13

CARTITUDE-10

Plasma cell

Multiple Myeloma

NCT07266441 2026-03-13

TRIlogy-3

157 enrolled

Plasma cell

Multiple Myeloma

NCT05755113 2026-03-12

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

40 enrolled

Sarcoma

Neoplasm Metastasis, Sarcoma

NCT05968326 2026-03-12

IMCODE003

260 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT06567782 2026-03-12

AZUR-4

120 enrolled

Colonic Neoplasms

NCT07102381 2026-03-12

EmpowHER 208

125 enrolled

Breast

Breast Neoplasms

NCT07170644 2026-03-12

A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

18 enrolled

Sarcoma

Desmoid Tumors

NCT07221474 2026-03-12

INTerpath-13

180 enrolled

Squamous Non-small Cell Lung Cancer

NCT07284758 2026-03-12

MOMENTUM

Plasma cell

Multiple Myeloma

NCT07297212 2026-03-12

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

75 enrolled

CNS

Brain Neoplasms, Glioblastoma

NCT05061550 2026-03-11

NeoCOAST-2

630 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06504147 2026-03-11

A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

114 enrolled

Gynecologic

Ovarian Neoplasms, Peritoneal Neoplasms

NCT06959082 2026-03-11

Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

30 enrolled

Head & Neck

Head and Neck Cancer Squamous Cell Carcinoma

NCT07015242 2026-03-11

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

65 enrolled

Lymphoma

NCT07111546 2026-03-11

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

140 enrolled

Other solid neoplasm

Advanced Solid Tumour

NCT07196644 2026-03-11

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

125 enrolled

Other solid neoplasm

Solid Tumors Harboring MET Amplification

NCT05503797 2026-03-10

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

254 enrolled

CNS

Glioma

NCT05967689 2026-03-10

REZILIENT2

220 enrolled

Carcinoma, Lung Diseases

NCT06414954 2026-03-10

SYNAPSE-MG

84 enrolled

Myasthenia Gravis

NCT06788912 2026-03-10

MK-3475-01E